Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury

The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Novel Mouse Model of Atherosclerotic Plaque Instability for Drug Testing and Mechanistic/Therapeutic Discoveries Using Gene and MicroRNA Expression Profiling

(2013) Yung-Chih Chen et al.   CIRCULATION RESEARCH

Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis

(2013) Myeong Ho Yoon et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

(2013) Adam J. Pawson et al.   NUCLEIC ACIDS RESEARCH

Non-endothelial cell endothelin-B receptors limit neointima formation following vascular injury

(2012) N. S. Kirkby et al.   CARDIOVASCULAR RESEARCH

Defining the affinity and receptor sub-type selectivity of four classes of endothelin antagonists in clinically relevant human cardiovascular tissues

(2012) Janet J. Maguire et al.   LIFE SCIENCES

Comparison of endothelin receptors in normal versus cirrhotic human liver and in the liver from endothelial cell-specific ETB knockout mice

(2012) Lowell Ling et al.   LIFE SCIENCES

Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways

(2012) Janet J. Maguire et al.   LIFE SCIENCES

Pathological Importance of the Endothelin-1/ETBReceptor System on Vascular Diseases

(2012) Kento Kitada et al.   Cardiology Research and Practice

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1This article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.

(2010) N.F. Kelland et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early Atherosclerosis

(2010) Martin Reriani et al.   CIRCULATION

In-Stent Restenosis in the Drug-Eluting Stent Era

(2010) George D. Dangas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inhibition of Endothelin ETB Receptor System Aggravates Neointimal Hyperplasia after Balloon Injury of Rat Carotid Artery

(2009) K. Kitada et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

(2007) N S Kirkby et al.   BRITISH JOURNAL OF PHARMACOLOGY